Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shadi Haddadin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Lung Cancer|May 10, 2011
History of small-cell lung cancerShadi Haddadin, Michael C Perry
Current Clinical Pharmacology|February 17, 2010
Intraperitoneal drug therapy: an advantageKunal Chaudhary, Shadi Haddadin, Ravi Nistala, et al.
Oncology Letters|April 20, 2013
Gemcitabine and cisplatin-induced tumor lysis syndrome in a patient with gallbladder carcinoma: A case reportDeiter J Duff, Shadi Haddadin, Carl Freter, et al.
International Journal of Clinical and Experimental Pathology|September 10, 2011
Plasma microRNAs as novel biomarkers for early detection of lung cancerDali Zheng, Shadi Haddadin, Yong Wang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Lung Cancer|May 10, 2011
History of small-cell lung cancerShadi Haddadin, Michael C Perry
Current Clinical Pharmacology|February 17, 2010
Intraperitoneal drug therapy: an advantageKunal Chaudhary, Shadi Haddadin, Ravi Nistala, et al.
Oncology Letters|April 20, 2013
Gemcitabine and cisplatin-induced tumor lysis syndrome in a patient with gallbladder carcinoma: A case reportDeiter J Duff, Shadi Haddadin, Carl Freter, et al.
International Journal of Clinical and Experimental Pathology|September 10, 2011
Plasma microRNAs as novel biomarkers for early detection of lung cancerDali Zheng, Shadi Haddadin, Yong Wang, et al.
Pageof 1